Related references
Note: Only part of the references are listed.Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Pingzheng Mo et al.
CLINICAL INFECTIOUS DISEASES (2021)
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Preeti Malik et al.
BMJ EVIDENCE-BASED MEDICINE (2021)
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Giuseppe Lippi et al.
CLINICA CHIMICA ACTA (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Zhongliang Wang et al.
CLINICAL INFECTIOUS DISEASES (2020)
Old and new antirheumatic drugs for the treatment of COVID-19
Maurizio Benucci et al.
JOINT BONE SPINE (2020)
Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
Luca Quartuccio et al.
JOINT BONE SPINE (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early
Chaochao Tan et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis
Long-quan Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
Litao Zhang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Could ferritin help the screening for COVID-19 in hemodialysis patients?
Stanislas Bataille et al.
KIDNEY INTERNATIONAL (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Mild versus severe COVID-19: Laboratory markers
Thirumalaisamy P. Velavan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu
Yongli Zheng et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
Nicola Veronese et al.
FRONTIERS IN MEDICINE (2020)
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study
Haiyan Qiu et al.
LANCET INFECTIOUS DISEASES (2020)
The role of biomarkers in diagnosis of COVID-19-A systematic review
Muhammed Kermali et al.
LIFE SCIENCES (2020)
Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
Jenifer Gomez-Pastora et al.
CLINICA CHIMICA ACTA (2020)
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
Jing Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Investigation and management of a raised serum ferritin
Jonathan O. Cullis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis
Steven Grange et al.
CRITICAL CARE MEDICINE (2016)
The Hyperferritinemic Syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome
Cristina Rosario et al.
BMC MEDICINE (2013)
Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients
Soken-Nakazawa J. Song et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Share Paper
